Last month I reported that “probiotaceuticals” are likely going to be the next bubble in pharmaceuticals. Knowing Big Pharma, they will come up with a name like “buggutexx” (I should patent it): “A poorly appreciated truism is that the information contained within the mammalian genome

We knew it was coming; it was only a matter of time. Ever since the New England J. of Medicine published the article that finally addressed the true mechanism of how cholesterol drugs work, I waited for the other shoe to drop: if regulators agree, the pool of people in the United Stat

“Until America has learned to love literature not as an amusement, not as a mere doggerel to memorize in college, but for its humanizing and ennobling energy, she will not  have succeeded in that high sense which alone makes a nation out of people; that which raises it from a dead nam

 “The current compendia [of chemotherapy] lack transparency, cite little current evidence, lack systematic methods to review and update evidence, and are replete with conflict-of-interest issues… The findings would seem to matter. Up to 75% of all uses of cancer therapies are off labe